左西孟旦在心血管疾病的研究进展
Research Progress of Levosimendan in Cardiovascular Diseases
DOI: 10.12677/ACM.2024.143783, PDF,   
作者: 王学文*：山东第一医科大学(山东省医学科学院)研究生部，山东 济南；闫素华#：山东第一医科大学第一附属医院心血管内科，山东 济南
关键词: 左西孟旦；心血管疾病；安全性和有效性；Levosimendan； Cardiovascular Disease； Efficacy and Safety
摘要: 左西孟旦LS (Levosimendan, LS)作为一种新型钙增敏剂，其增加心肌收缩力、扩张外周血管和冠状动脉的同时，还具有肝脏、肾脏、肺等器官保护作用。动物实验中发现，LS还具有抗炎、抗氧化、抗血栓形成和前纤维蛋白溶解作用。LS的作用特点是增强心肌收缩力的同时不增加心肌耗氧，不会对舒张功能产生影响，因此适用于需要增加心肌收缩力的急性失代偿性心力衰竭(Acute Decom-pensated Heart Failure, ADHF)患者的短期治疗。此外，在心源性休克、感染性休克、肺心病、扩张型心肌病(Dilated Cardiomyopathy, DCM)的治疗中以及外科围手术期联合应用LS，患者心功能改善更加明显，且安全性较好。
Abstract: Levosimendan (LS), as a new calcium sensitizer, can increase myocardial contractility, dilate pe-ripheral and coronary arteries, and protect organs such as liver, kidney and lung. Animal experi-ments have found that LS also has anti-inflammatory, anti-oxidation, anti-thrombosis and profibri-nolytic effects. LS is characterized by enhancing myocardial contractility without increasing myo-cardial oxygen consumption and having no effect on diastolic capacity. It is suitable for the short-term treatment of Acute Decompensated Heart Failure (ADHF) that needs to increase myo-cardial contractility. In addition, LS can significantly improve cardiac function and relieve clinical symptoms in patients with cardiogenic shock, septic shock, pulmonary heart disease, dilated car-diomyopathy (DCM) and surgical perioperative period.
文章引用：王学文, 闫素华. 左西孟旦在心血管疾病的研究进展[J]. 临床医学进展, 2024, 14(3): 862-869. https://doi.org/10.12677/ACM.2024.143783

参考文献

[1] 朱子雄, 李学文. 左西孟旦治疗心力衰竭研究进展[J]. 中西医结合心脑血管病杂志, 2023, 21(5): 863-865.
[2] Varshney, A. and Agarwal, N. (2022) Incidence of Arrhythmias in COVID-19 Patients with Double Mutant Strain of SARS-CoV-2 Virus: A Tertiary Care Experience. Global Cardiology Science and Practice, 2022, E202216. [Google Scholar] [CrossRef] [PubMed]
[3] Wanderer, S., Mrosek, J., Gessler, F., et al. (2018) Levosimendan Re-duces Prostaglandin F2a-Dependent Vasoconstriction in Physiological Vessels and after Experimentally Induced Sub-arachnoid Hemorrhage. Current Neurovascular Research, 15, 72-80. [Google Scholar] [CrossRef] [PubMed]
[4] 陈元椿. 左西孟旦、米力农对AHF患者的疗效及对血清NT-ProBNP、NE和 ET-1水平的影响分析[J]. 心血管康复医学杂志, 2018, 27(3): 313-317.
[5] 崔雪萍, 邹应梅. 左西孟旦在呼吸系统疾病中的研究进展[J]. 中国医药, 2023, 18(7): 1080-1084.
[6] 李晓玲, 王丹, 肖扬, 等. LS对缺氧复氧诱导的H9C2细胞凋亡、PTEN和PI3K/Akt信号通路的影响[J]. 中国动脉硬化杂志, 2022, 30(11): 942-948.
[7] 刘永利. 左西孟旦对H2O2所致大鼠心肌细胞氧化损伤的保护作用[D]: [硕士学位论文]. 长春: 吉林大学, 2014.
[8] 李秋霞, 慕春言. 伊伐布雷定联合左西孟旦治疗慢性心力衰竭的临床研究[J]. 现代药物与临床, 2019, 34(6): 1630-1634.
[9] 刘亚丽, 李春彦, 李雅丽, 等. 左西孟旦对大鼠急性心肌梗死后心肌纤维化及心功能的影响[J]. 中国临床解剖学杂志, 2022, 40(1): 49-54.
[10] 黄泓轲, 罗健玮, 冉华. 左西孟旦通过调控EGOT/微小RNA-641对缺氧/复氧心肌细胞纤维化的影响[J]. 解剖学报, 2022, 53(4): 479-487.
[11] 张宏, 王连友, 邓应彪, 等. 左西孟旦联合布美他尼治疗急性左心衰竭的效果及对血管内皮功能的影响[J]. 中国药物滥用防治杂志, 2023, 29(10): 1783-1787.
[12] Huang, H.C., Tsai, H.J., Wang, C.C., et al. (2017) Levosimendan Mit-igates Coagulopathy and Organ Dysfunction in Rats with Endotoxemia. Journal of the Chinese Medical Association, 80, 432-441. [Google Scholar] [CrossRef] [PubMed]
[13] Abdelrahman, A.M., Al Salam, S., Al Suleimani, Y., Ashique, M., Manoj, P. and Ali, B.H. (2020) Effect of Levosimendan, an Inodilator, on Streptozotocin-Induced Diabetic Nephropathy in Rats. European Journal of Pharmacology, 873, Article ID: 172960. [Google Scholar] [CrossRef] [PubMed]
[14] Erbüyün, K., Vatansever, S., et al. (2009) Effects of Levosi-Mendan and Dobutamine on Experimental Acute Lung Injury in Rats. Acta Histochemica, 111, 404-414. [Google Scholar] [CrossRef] [PubMed]
[15] Krychtiuk, K.A., Kaun, C., Hohensinner, P.J., et al. (2017) An-ti-Thrombotic and Pro-Fibrinolytic Effects of Levosimendan in Human Endothelial Cells in Vitro. Vascular Pharmacol-ogy, 90, F44-F50. [Google Scholar] [CrossRef] [PubMed]
[16] Kaptan, K., Erinç, K., Ifran, A., et al. (2008) Levosimendan Has an Inhibitory Effect on Platelet Function. American Journal of Hematology, 83, 46-49. [Google Scholar] [CrossRef] [PubMed]
[17] Noé, L., Peeters, K., Izzi, B., et al. (2010) Regulators of Platelet CAMP Levels: Clinical and Therapeutic Implications. Current Medicinal Chemistry, 17, 2897-2905. [Google Scholar] [CrossRef] [PubMed]
[18] 中华医学会心血管病学分会, 中华心血管病杂志编辑委员会. 中国心力衰竭诊断和治疗指南2014[J]. 中华心血管病杂志, 2014, 42(2): 98-122.
[19] 朱艳卫, 赵国安. 左西孟旦对急性失代偿性心衰的疗效观察[J]. 河南科技大学学报(医学版), 2018, 36(1): 53-55.
[20] 张鹏. LS与人脑利钠肽在重度心衰患者中的治疗效果观察[J]. 临床医药文献电子杂志, 2017, 4(54): 10625-10626.
[21] 陈永清, 蔡晓庆, 胡威, 等. 左西孟旦治疗心血管危重症的临床研究进展[J]. 心脏杂志, 2018, 30(1): 113-116.
[22] 张笑笑, 赵冰, 翟晋慧, 等. 左西孟旦对急性心肌梗死合并心源性休克患者PCI术后的疗效评价[J]. 中国循证心血管医学杂志, 2023, 15(3): 311-315.
[23] 周宏伟, 罗秀英. 新活素联合左西孟旦治疗急性心肌梗死合并心源性休克的临床疗效研究[J]. 保健医学研究与实践, 2022, 19(2): 9-14.
[24] Omerovic, E., Ramunddal, T., Albertsson, P., et al. (2010) Levosimendan neither Improves nor Worsens Mortality in Patients with Cardio-Genic Shock Due to ST-Elevation Myocardial Infarction. Vascular Health and Risk Management, 6, 657-663. [Google Scholar] [CrossRef] 
[25] Braun, J.P., Schneider, M., Dohmen, P., et al. (2004) Successful Treatment of Dilative Cardiomyopathy in a 12-Year-Old Girl Using the Calcium Sensitizer Levosimendan after Weaning from Mechanical Biventricular Assist Support. Journal of Cardiothoracic and Vascular Anesthesia, 18, 772-774. [Google Scholar] [CrossRef] [PubMed]
[26] Morelli, A., Teboul, J.L., Maggiore, S.M., et al. (2006) Effects of Levosimen Dan on Right Ventricular after Load in Patients with Acute Respiratory Distress Syndrome: A Pilot Study. Critical Care Medicine, 34, 2287-2293. [Google Scholar] [CrossRef] 
[27] 左凌云, 裴飞, 李晓云, 等. 左西孟旦对感染性休克合并心功能不全患者心功能及预后的影响[J]. 热带医学杂志, 2023, 23(4): 528-533.
[28] 于巍巍, 何震. 左西孟旦联合短程脉冲式高容量血液滤过对ICU感染性休克患者血流动力学及氧合指标的影响[J]. 医学理论与实践, 2021, 34(9): 1515-1517.
[29] 刘艳芬, 刘亚北. 左西孟旦治疗联合酚妥拉明治疗肺心病引起右心衰竭的临床分析[J]. 临床研究, 2023, 31(12): 85-88.
[30] 杨立慧. 左西孟旦与托伐普坦联合治疗肺源性心脏病并难治性心力衰竭的疗效[J]. 慢性病学杂志, 2023, 24(7): 1048-1050.
[31] 戚刚强, 傅恩清, 臧宇. 左西孟旦治疗慢性肺心病右心功能衰竭的疗效分析[J]. 中华肺部疾病杂志(电子版), 2019, 12(3): 330-332.
[32] 胡乐义, 周姝, 程景林. 左西孟旦治疗扩张型心肌病患者的短期疗效分析和安全性观察[J]. 实用检验医师杂志, 2022, 14(4): 394-398.
[33] Kayvanpour, E., Sedaghat-Hamedani, F., Amr, A., et al. (2017) Genotype-Phenotype Associations in Dilated Cardiomyopathy: Meta-Analysis on More than 8000 Individuals. Clinical Research in Cardiology, 106, 127-139. [Google Scholar] [CrossRef] [PubMed]
[34] Motegi, S., Uchiyama, A., Yamada, K., et al. (2016) Increased Susceptibility to Oxidative Stress- and Ultraviolet A-Induced Apoptosis in Fibroblasts in Atypical Progeroid Syn-drome/Atypical Werner Syndrome with LMNA Mutation. Experimental Dermatology, 25, 20-27. [Google Scholar] [CrossRef] [PubMed]
[35] 袁文金, 李文峰, 罗刚, 等. 左西孟旦对扩张型心肌病的作用及机制[J]. 中国老年学杂志, 2019, 39(1): 175-177.
[36] 肖大宴. 左西孟旦治疗老年扩张型心肌病急性心力衰竭的疗效及对免疫功能的影响[J]. 中国老年学杂志, 2019, 39(16): 3873-3875.
[37] 何浪, 陈志平, 陈宇宁, 等. 左西孟旦治疗老年扩张型心肌病合并肾功能不全患者的疗效和安全性分析[J]. 浙江医学, 2019, 41(4): 359-361.
[38] 李维, 夏中元, 孟庆涛, 等. 左孟西旦对心脏手术患者围术期心指数影响的Meta分析[J]. 武汉大学学报(医学版), 2017, 38(5): 856-860.
[39] 李政, 葛圣林, 张成鑫. 左西孟旦在体外循环心脏手术中的心肌保护作用[J]. 安徽医科大学学报, 2013, 48(6): 698-700.
[40] Ponschab, M., Hochmair, N., Ghazwinian, N., et al. (2008) Levosimendan Infusion Improves Haemodynamics in Elderly Heart Failure Patients Undergoing Urgent Hip Fracture Repair. European Journal of Anaesthesiology, 25, 627-633. [Google Scholar] [CrossRef] 
[41] Katsaragaki, S., Kapralou, A., Drimousis, P., et al. (2009) Prophylactic Preoperative Levosimendan Administration in Heart Failure Patients Undergo-ing Elective Non-Cardiac Surgery: A Preliminary Report. Hellenic Journal of Cardiology, 50, 185-192.
[42] 鞠静, 王志勇. 多巴胺联合左西孟旦、硝普钠治疗老年重症心衰患者的疗效及安全性分析[J]. 系统医学, 2023, 8(1): 138-141.
[43] 庞轩, 储红梅. 重组人脑利钠肽联合左西孟旦治疗老年失代偿性心力衰竭的疗效及安全性[J]. 国际老年医学杂志, 2022, 43(3): 330-333.
[44] 郭红雨. 左西孟旦治疗急性心肌梗死并发泵衰竭的疗效及安全性分析[J]. 齐齐哈尔医学院学报, 2017, 38(22): 2653-2654.

为你推荐